WallStreetZenWallStreetZen

NASDAQ: IXHL
Incannex Healthcare Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

IXHL past revenue growth

How has IXHL's revenue growth performed historically?
Company
-0.95%
Industry
253.41%
Market
17.29%
IXHL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IXHL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

IXHL earnings and revenue history

Current Revenue
$788.7k
Current Earnings
-$18.2M
Current Profit Margin
-2,306.2%

IXHL Return on Equity

Current Company
-32.1%
Current Industry
9.2%
Current Market
184.9%
IXHL's Return on Equity (-32.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IXHL announces earnings.

IXHL Return on Assets

Current Company
-31.6%
Current Industry
4.4%
IXHL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IXHL Return on Capital Employed

Current Company
-19.33%
Current Industry
10.3%

IXHL vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IXHL$788.65k-$18.19M-$18.19M-0.95%N/A
HUGE$0.00-$14.04M-$17.38MN/AN/A
UPXI$64.11M$3.19M-$2.61M+143.69%N/A
THTX$59.30M-$28.46M-$34.99M+15.68%N/A
RLMD$0.00-$157.04M-$157.04MN/AN/A
View Top Pharmaceutical Stocks

Incannex Healthcare Earnings & Revenue FAQ

What were IXHL's earnings last quarter?

Incannex Healthcare (NASDAQ: IXHL) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total Incannex Healthcare earnings for the quarter were N/A. In the same quarter last year, Incannex Healthcare's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Incannex Healthcare stock.

What was IXHL's earnings growth in the past year?

As of Q1 2023, Incannex Healthcare's earnings has grown year over year. Incannex Healthcare's earnings in the past year totalled -$18.19 million.

What was IXHL's revenue last quarter?

Incannex Healthcare (NASDAQ: IXHL) reported Q4 2022 revenue of N/A up N/A year over year. In the same quarter last year, Incannex Healthcare's revenue was N/A.

What was IXHL's revenue growth in the past year?

As of Q1 2023, Incannex Healthcare's revenue has grown -0.95% year over year. This is 254.35 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 253.41%. Incannex Healthcare's revenue in the past year totalled $788.65 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.